Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used